From: Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer
Factor
HR OS
P OS
HR PFS
P PFS
Age (> 58)
5.3 (1.7–17.0)
0.005
3.2 (1.3–7.8)
0.01
ColXα1
2.1 (1.2–3.9)
1.8 (1.6–5.7)
Clinical Stage
2.6 (1.3–5.2)
0.008
2.7 (1.6–4.7)
< 0.001